Evidence map›Paper›PMID 40401109›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2025

The reproducibility of [68Ga]Ga-FAPI-04 PET uptake parameters at 15 min and 60 min post-injection.

Hongyu Meng, Guixia Pan, Ye Peng, Jian Yang, Bin Cui, Yingying Zhang, Xiaojiao Wang, Siyu Liang, Haojun Chen, Changjing Zuo and 2 more

Abstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Repeatability of semi-quantitative [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hongyu MengDepartment of Radiology, Shanghai Fourth People's Hospital Affiliated to Tongji University, School of Medicine Shanghai, China.
Guixia PanDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Ye PengDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Jian YangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Bin CuiDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Yingying ZhangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Xiaojiao WangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Siyu LiangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Haojun ChenDepartment of Nuclear Medicine and Minnan PET Center, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China.
Changjing ZuoDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Zeyu ZhangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.
Chao ChengDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gallium-68 labeled fibroblast activation protein inhibitor ([68Ga]Ga-FAPI-04) can be visualized just 15 min post-injection. However, the appearance of imaging at 15 and 60 min remains unclear. This study aimed to explore the relationship between quantitative values in [68Ga]Ga-FAPI-04 PET, specifically at 15 and 60 minutes post-injection, in patients with various tumor. We enrolled 30 patients with cancer who underwent [68Ga]Ga-FAPI-04 PET/CT scan between January 2021 and February 2025 at our institute. Image acquisition was performed using a PET/CT scanner at 15 min and 60 min after [68Ga]Ga-FAPI-04 injection. The maximum, mean and peak standardized uptake value (SUV

Indexed as

FAPIPET/CTreproducibilitySUVTLRUTV

Identifiers

PMID40401109
PMCPMC12089092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.